| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Forte Biosciences, Inc. (FBRX) has 2 insiders with recent SEC Form 4 filings, including 15 buys and 3 sells. FBRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 180.0K | $4.71M | - | |
| CFO | 60.0K | $1.57M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Riley Antony A65 | Chief Financial Officer | Buy | 9,680 | $26.33 | $254,832.78 | +30.4% | +0.2% | - | |
| Nov 21, 2024 | Riley Antony A65 | Chief Financial Officer | Buy | 22,514 | $5.55 | $124,997.73 | +272.5% | -36.0% | +17.7% | |
| Dec 18, 2023 | Wagner Paul A.76 | See Remarks | Buy | 10,000 | $0.75 | $7,525.00 | +0.6% | -10.2% | +9.8% | |
| Dec 14, 2023 | Wagner Paul A.76 | See Remarks | Buy | 20,520 | $0.71 | $14,551.38 | +0.6% | -6.2% | +34.0% | |
| Dec 12, 2023 | Wagner Paul A.76 | See Remarks | Buy | 29,776 | $0.65 | $19,275.66 | +0.8% | +8.3% | +46.3% | |
| Dec 8, 2023 | Wagner Paul A.76 | See Remarks | Buy | 51,203 | $0.60 | $30,467.89 | +1.5% | +26.1% | +83.6% | |
| Nov 22, 2023 | Wagner Paul A.76 | See Remarks | Buy | 7,366 | $0.44 | $3,219.89 | +0.1% | +62.8% | +45.5% | |
| Dec 16, 2022 | Wagner Paul A.76 | See Remarks | Buy | 100,000 | $1.05 | $104,672.10 | +3.8% | +0.7% | -23.5% | |
| Sep 7, 2021 | Riley Antony A65 | Chief Financial Officer | Sell | 25,000 | $4.24 | $106,105.48 | -49.4% | -46.5% | -68.5% | |
| Sep 7, 2021 | Wagner Paul A.76 | See Remarks | Sell | 1,000,000 | $4.35 | $4,347,100.00 | -43.9% | -46.5% | -68.5% |